Simcere Pharmaceutical Group Limited (HKG:2096)

HKG:2096 Revenue

Simcere Pharmaceutical Group had revenue of 4.58B CNY in the half year ending June 30, 2026, with 47.10% growth. This brings the company's revenue in the last twelve months to 8.73B, up 22.80% year-over-year. In the year 2025, Simcere Pharmaceutical Group had annual revenue of 7.73B with 16.52% growth.

• Revenue (ttm): 8.73B CNY
• Revenue Growth: +22.80%
• P/S Ratio: 2.80
• Revenue / Employee: 1.24M CNY
• Employees: 7,064
• Market Cap: 28.22B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	7.73B	1.10B	16.52%
Dec 31, 2024	6.64B	27.41M	0.41%
Dec 31, 2023	6.61B	283.72M	4.49%
Dec 31, 2022	6.32B	1.32B	26.49%
Dec 31, 2021	5.00B	491.00M	10.89%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 31, 2026

Data Sources Report a data error